Robert Obert, MD
Otolaryngology · Saint Louis, MONPI 1891880225
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Optinose US, Inc. at 44.7% of the total. Reporting peaked in 2019 at $3,507 and has fallen 81.9% since, to $636 in 2025. Among otolaryngology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $140.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$3K
- Inspire Medical Systems, Inc.$3K
- Intersect ENT, Inc.$269
- Acclarent, Inc$204
- Integra Lifesciences Corporation$137
- Stryker$128
- plus $29 from 1 others
What the payments were for
- Consulting fees$2,50036%
- Travel & lodging$1,56222%
- Food & beverage$2,97642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 10 | $3,146 |
| Inspire Medical Systems, Inc. | 29 | $3,125 |
| Intersect ENT, Inc. | 3 | $269 |
| Acclarent, Inc | 5 | $204 |
| Integra Lifesciences Corporation | 1 | $137 |
| Stryker | 1 | $128 |
| Davol Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$2,910
- Inspire$2,152
- Inspire Upper Airway Stimulation System$374
- SINUVA$143
- Acclarent Aera$137
- Inspira Air$137
- RELIEVA SPINPLUS NAV$137
- TruDi Probe$137
- XPRESS ENT DILATION SYSTEM$128
How this compares
$7,038 in reported general payments places this provider in the 90th percentile of 210 otolaryngology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 15 | $10,266 |
| Ipratropium Bromide | 299 | $7,739 |
| Azelastine Hcl | 212 | $4,503 |
| Fluticasone Propionate | 273 | $3,643 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 17 | $2,326 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 18 | $1,847 |
| Mometasone Furoate | 36 | $694 |
| Doxycycline Hyclate | 81 | $606 |
| Ondansetron OdtOndansetron | 110 | $553 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 108 | $543 |
| Pantoprazole Sodium | 53 | $507 |
| Cefdinir | 19 | $314 |
| Nystatin | 15 | $249 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $190 |
| Mupirocin | 15 | $148 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $3,146 | $10,26615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 210 otolaryngology providers in Missouri.
Other otolaryngology in Saint Louis
- Ryan JacksonSaint Louis$284K
- Ravindra UppaluriSaint Louis$168K
- John SchneiderSaint Louis$74K
- Amit WaliaSaint Louis$21K
- Bharat PanugantiSaint Louis$19K
- Cristine Klatt-CromwellSaint Louis$13K
- Lauren RolandSaint Louis$11K
- James HartmanSaint Louis$7K
- Barry RosenblumSaint Louis$4K
- Arya NaminSaint Louis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.